Cellpeuticssp. z o.o.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2015-12-11
Share capital
20,000.00 PLN
Registered address
ul. Duńska 9, 54-427 Wrocław, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 2 of 6 financial statements were filed late (the longest delay 144 days for 2021).

  • 2025not filed
  • 202403/05/2025
  • 202314/07/2024
  • 202205/03/2023
  • 202106/12/2022
  • 202004/06/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Division · Scientific research and development1,779 / 1,953
Top 91%
Voivodeship · Dolnośląskie38,930 / 41,332
Top 94%
Country · Poland466,228 / 495,860
Top 94%

Results vs industry

Revenue
This companyUSD 151.48MedianUSD 73.26kAverageUSD 3.23m
Net profit
This companyUSD -8.43kMedianUSD 69.70AverageUSD 82.18k
Operating costs
This companyUSD 3.63kMedianUSD 75.78kAverageUSD 3.04m
Assets
This companyUSD 344.72kMedianUSD 119.88kAverageUSD 3.90m

Public procurement

2 tenders recorded as contracting authority.

Notices (contracting authority)

SubjectAmount
Poland-Wrocław: Medical kits
–
Poland-Wrocław: Medical kits
–

Authorized Representatives

Vladimír Bobek – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Vladimír Bobekage 52
–$2,755.2751%
Katarina Kolostova
98$2,647.2249%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2016-06-03.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$14,526

European Funds

ProjectEU co-financing
Circulating sporadic cells in the diagnosis and treatment of endometriosis.
$700.9K

Competitors

Name
Navalgosp. z o.o.
MedisensonicS.A.
123labs.Eusp. z o.o.
Aliatechnicssp. z o.o.
Sigmatiksp. z o.o.
Deepstributedsp. z o.o.
Zero Analogsp. z o.o.
Univectsp. z o.o.
Bekarsp. z o.o.
Quetzsp. z o.o.

Change history

DateEvent
2018-02-22Address change
2015-12-11Entered in the register

FAQ

Last updated: 2026-04-15